NH TherAguix NEWS

NH TherAguix Announces the completion of Phase I Recruitment for the Pancreas Cohort and the entry into Phase II in the NANOSMART phase Ib/II trial.

NHT today announced the transition to the Phase II randomized part of the NANOSMART study in the cohort of patients with pancreatic tumors